Hemostat is a chemical agent that is used for wound closure and prevents from excessive blood flow. Hemostats are highly effective products used during surgeries and operations to control blood loss. These products come in different forms such as sponges, gauzes, strips, films, powders and others. Increasing geriatric population and rising adoption of hemostat products by medical practitioners is expected to drive growth of the India hemostat market.
However, there is low acceptance among medical practitioners and healthcare professional owing to low awareness. Hence, creating awareness among key opinion leaders such as healthcare professionals could open up opportunities for growth of the India hemostat market in the near future.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2015, the Indian hemostat market was valued at US$ 54.1 Mn and is expected to expand at a CAGR of 5.8% over 2016–2025. This expected growth is attributed to advancements in hemostat products and increasing adoption of hemostat products by medical practitioner and surgeons, fuelled by an increase in number of surgeries and trauma cases across the country.
Economic factors such as rise in disposable income and provision of medical reimbursement policies are expected to drive market growth in the country. Surgeons shifting from traditional to new conventional methods for blood clotting is fuelling growth of hemostat market in India. However, various factors such as lower awareness of hemostat, high priced products and government regulations for hemostat is expected to inhibit market growth.
Market Segmentation by Product Type
By product type, the India hemostat market is segmented into mechanical type and flowable type. Mechanical type segment includes gauzes, sponges, strips and films, and flowable type includes powder type segment. Currently, the mechanical type segment accounts for highest market share in the India hemostat market, and is expected to continue to remain the dominant type in terms of value during the forecast period as preference for this type among healthcare professional is high.
By product material form, the hemostat market is segmented into gelatin material and oxidised cellulose material segments. Gelatin material is used for manufacturing gauzes, sponges, films, strips and powder and oxidised cellulose is used in hemostat strips. Currently the gelatin material form accounts for highest market share in the India hemostat market, and this trend is expected to continue in terms of value during the forecast period. This is attributed to high preference among healthcare professionals for this type of product as it absorbs blood more quickly.
In terms of application, hemostat are used during surgeries and this segment is expected to account for over 50% of the revenue generated in the India’s hemostat market. Revenue from the trauma cases is expected to increase at the highest CAGR over the forecast period as compared to surgeries.
Principal Consultant
By distribution channel, hospital segment is expected to register an exceptional CAGR during the forecast period owing to increase in adoption rate of hemostat products and acceptance of these products by surgeons and medical practitioners. Ambulatory surgical centre segment is expected to exhibit a constant market share owing to high patient inflow at ASCs due to reimbursement for surgeries from insurance payer, which will result in decreased healthcare expenditure.
Key market players covered in this report are Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals and Mil Laboratories.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Segmentation on basis of Product Type
Segmentation on basis of Product Material Base
Segmentation on basis of Application
Segmentation on basis of Distribution Channel
Segmentation on basis of Geography
India
The India Hemostat market is likely to secure a CAGR of 5.5% through 2032.
The India Hemostat market size is estimated to cross US$ 134.43 Mn by 2032.
The India Hemostat market is likely to record a value of US$ 78.70 Mn in 2022.
India is likely to lead the Hemostat market.
1. Assumptions and Acronyms Used 2. Research Methodology 3. Executive Summary 4. India Market Overview 4.1. Introduction 4.1.1. India Market Definition 4.1.2. India Market Taxonomy 4.2. India Market Product Overview 4.3. India Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity 4.3.4. Primary Insights for Products in India 4.3.5. PEST Analysis 4.4. India Market Forecast, 2016-2026 4.4.1. Market Value Forecast 4.4.1.1. Y-o-Y Growth Projections 4.4.1.2. Absolute $ Opportunity 4.5. India Market Trends 4.6. India Market Snapshot (2015) 4.6.1. Market Share, By Product 4.6.2. Market Share, By End User 5. India Market Analysis, By Product 5.1. Introduction 5.1.1. Y-o-Y Growth Comparison, By Product 5.1.2. Market Share & Basis Point (BPS) Analysis, By Product 5.2. India Market Forecast, By Material -base 5.2.1. Porcine Gelatin 5.2.1.1. Absolute $ Opportunity 5.2.1.2. Market Value Forecast 5.2.2. Oxidized regenerated cellulose 5.2.2.1. Absolute $ Opportunity 5.2.2.2. Market Value Forecast 5.3. India Market Attractiveness Analysis, By Material 5.4. India Market Prominent Trends, By Material 5.5. India Market Forecast, By Product Form 5.5.1. Mechanical 5.5.1.1. Absolute $ Opportunity 5.5.1.2. Market Value Forecast 5.5.2. Flowable 5.5.2.1. Absolute $ Opportunity 5.5.2.2. Market Value Forecast 5.6. India Market Attractiveness Analysis, By Forms 5.7. India Market Prominent Trends, By Forms 6. India Market Analysis, By Applications 6.1. Introduction 6.1.1. Y-o-Y Growth Comparison, By 6.1.2. Market Share & Basis Point (BPS) Analysis, By 6.2. India Market Forecast, By Applications 6.2.1. Surgery 6.2.1.1. Absolute $ Opportunity 6.2.1.2. Market Value Forecast 6.2.2. Trauma Cases 6.2.2.1. Absolute $ Opportunity 6.2.2.2. Market Value Forecast 6.3. India Market Attractiveness Analysis, By Applications 6.4. India Market Prominent Trends, By Applications 7. India Market Analysis, By Distribution Channels 7.1. Introduction 7.1.1. Y-o-Y Growth Comparison, By Distribution Channel 7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channel 7.2. India Market Forecast, By Distribution Channel 7.2.1. Hospitals and Surgical Centers 7.2.1.1. Absolute $ Opportunity 7.2.1.2. Market Value Forecast 7.2.2. Clinics 7.2.2.1. Absolute $ Opportunity 7.2.2.2. Market Value Forecast 7.2.3. Ambulatory Services 7.2.3.1. Absolute $ Opportunity 7.2.3.2. Market Value Forecast 7.2.4. Online Channels 7.2.4.1. Absolute $ Opportunity 7.2.4.2. Market Value Forecast 7.3. India Market Attractiveness Analysis, By Distribution Channel 7.4. India Market Prominent Trends, By Distribution Channel 7.5. Drivers & Restraints: Impact Analysis 8. Competition Landscape 8.1. Competition Dashboard 8.2. Company Profiles 8.2.1. Revenue 8.2.2. Products/Brand Offerings 8.2.3. Key developments 8.2.4. SWOT Analysis 8.2.5. Company Highlights 8.2.5.1. Ethicon US, LLC 8.2.5.2. Aegis Lifesciences 8.2.5.3. Eucare 8.2.5.4. Mil Laboratories 9. Key Takeaways and Strategic Recommendations
Explore Healthcare Insights
View Reports
Hemostat Market
